The future of pharma pricing, reimbursement and market access

By Dr Nicola Davies

One thing is certain: the payer landscape is changing. However, the best way for industry players to respond to the changes remains unclear. The 2nd Annual Pharma Pricing, Reimbursement and Market Access 2016, held in London, brought together pharmaceutical, biotechnology, health insurance, managed care, public policy and regulatory professionals and experts.

The event provided an overview of the pricing, market access, reimbursement and cost management issues and trends in global pharma. Although the focus of the policy reforms discussed at the conference was in the European Union region, the trends, challenges and key insights shared by speakers were highly applicable to FDA activities.